Covered recipient · General Payments record
NATALIE E PALOMBINI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$2,121.11
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,441.22 | 48 |
| Education | $13.08 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $180.68 | 5 |
| Incyte Corporation | $155.25 | 2 |
| ABBVIE INC. | $140.27 | 6 |
| Acerta Pharma LLC | $105.68 | 4 |
| Merck Sharp & Dohme Corporation | $92.24 | 3 |
| Ipsen Biopharmaceuticals, Inc | $79.50 | 2 |
| Janssen Biotech, Inc. | $71.11 | 3 |
| Coherus Biosciences Inc. | $68.08 | 2 |
| Alexion Pharmaceuticals, Inc. | $53.05 | 2 |
| Daiichi Sankyo Inc. | $48.47 | 2 |
| Genentech USA, Inc. | $45.95 | 2 |
| PFIZER INC. | $36.71 | 1 |
| SpringWorks Therapeutics, Inc. | $35.29 | 1 |
| SOBI, INC | $34.69 | 1 |
| Karyopharm Therapeutics Inc. | $30.46 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $29.86 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $29.28 | 1 |
| GENZYME CORPORATION | $28.66 | 1 |
| EISAI INC. | $24.95 | 1 |
| Kyowa Kirin, Inc. | $24.80 | 1 |
| Apellis Pharmaceuticals, Inc. | $22.09 | 1 |
| Blueprint Medicines Corporation | $21.94 | 1 |
| AVEO Pharmaceuticals, Inc. | $21.82 | 1 |
| Genmab U.S., Inc. | $21.50 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.83 | 1 |
| Acrotech Biopharma Inc. | $18.06 | 1 |
| Regeneron Healthcare Solutions, Inc. | $13.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (49)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.